• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes.社会经济地位与慢性移植物抗宿主病结局的关系。
Biol Blood Marrow Transplant. 2018 Feb;24(2):393-399. doi: 10.1016/j.bbmt.2017.10.009. Epub 2017 Oct 12.
2
Coping and Modifiable Psychosocial Factors are Associated with Mood and Quality of Life in Patients with Chronic Graft-versus-Host Disease.应对方式和可改变的心理社会因素与慢性移植物抗宿主病患者的情绪和生活质量相关。
Biol Blood Marrow Transplant. 2019 Nov;25(11):2234-2242. doi: 10.1016/j.bbmt.2019.06.024. Epub 2019 Jun 28.
3
Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life.眼部慢性移植物抗宿主病对生活质量的影响。
Biol Blood Marrow Transplant. 2015 Sep;21(9):1687-91. doi: 10.1016/j.bbmt.2015.05.020. Epub 2015 May 30.
4
Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.患者报告结局与皮肤慢性移植物抗宿主病的死亡率。
JAMA Dermatol. 2024 Apr 1;160(4):393-401. doi: 10.1001/jamadermatol.2023.6277.
5
Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantation.异基因造血细胞移植1年幸存者的社会经济状况与长期预后的关联
Bone Marrow Transplant. 2015 Oct;50(10):1326-30. doi: 10.1038/bmt.2015.166. Epub 2015 Jul 20.
6
Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium.慢性移植物抗宿主病评估中的握力和 2 分钟步行试验:来自慢性移植物抗宿主病联盟的分析。
Biol Blood Marrow Transplant. 2013 Jun;19(6):967-72. doi: 10.1016/j.bbmt.2013.03.014. Epub 2013 Mar 27.
7
Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial.患者报告结局和社会经济地位作为造血干细胞移植后临床结局的预测因素:来自血液和骨髓移植临床试验网络0902试验的一项研究
Biol Blood Marrow Transplant. 2016 Dec;22(12):2256-2263. doi: 10.1016/j.bbmt.2016.08.016. Epub 2016 Aug 23.
8
Racial, ethnic, and socioeconomic diversity and outcomes of patients with graft-versus-host disease: a CIBMTR analysis.患者移植物抗宿主病的种族、民族和社会经济多样性及其结果:CIBMTR 分析。
Blood Adv. 2024 Sep 24;8(18):4963-4976. doi: 10.1182/bloodadvances.2024013074.
9
Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.缓解与活动慢性移植物抗宿主病:对移植后生活质量的影响。
Biol Blood Marrow Transplant. 2019 Sep;25(9):1851-1858. doi: 10.1016/j.bbmt.2019.05.016. Epub 2019 May 24.
10
Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.年龄对慢性移植物抗宿主病患者生活质量、功能状态及生存的影响。
Biol Blood Marrow Transplant. 2014 Sep;20(9):1341-8. doi: 10.1016/j.bbmt.2014.05.001. Epub 2014 May 9.

引用本文的文献

1
Assessing Social Determinants of Health in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT.评估移植和CAR-T治疗受者的健康社会决定因素:美国血液与骨髓移植学会生存特别兴趣小组的专家小组建议
Transplant Cell Ther. 2025 Jul 23. doi: 10.1016/j.jtct.2025.07.017.
2
Annual household income and chronic pulmonary conditions in long-term survivors of blood or marrow transplantation: a BMTSS report.血液或骨髓移植长期幸存者的家庭年收入与慢性肺部疾病:一份BMTSS报告。
BMC Pulm Med. 2025 Jul 12;25(1):338. doi: 10.1186/s12890-025-03793-9.
3
Extended disability leave and related costs among employed patients with versus without graft-versus-host disease following hematopoietic stem cell transplantation.造血干细胞移植后发生与未发生移植物抗宿主病的在职患者的长期残疾假及相关费用
Support Care Cancer. 2025 Jun 5;33(7):543. doi: 10.1007/s00520-025-09561-z.
4
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part IV. Patient Important Outcomes.儿科移植与细胞治疗协会造血细胞移植后小儿慢性移植物抗宿主病生存的RESILIENT会议:第四部分。患者重要结局。
Transplant Cell Ther. 2025 Apr;31(4):224.e1-224.e13. doi: 10.1016/j.jtct.2024.12.019. Epub 2024 Dec 27.
5
Impact of payment source, referral site, and place of residence on outcomes after allogeneic transplantation in Mexico.支付来源、转诊地点及居住地址对墨西哥异基因移植术后结局的影响
World J Transplant. 2024 Jun 18;14(2):91052. doi: 10.5500/wjt.v14.i2.91052.
6
Disability Associated with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: Analysis of a Cross-Sectional US Patient Survey.异基因造血干细胞移植后与慢性移植物抗宿主病相关的残疾:一项美国患者横断面调查分析
Oncol Ther. 2024 Sep;12(3):451-464. doi: 10.1007/s40487-024-00288-1. Epub 2024 Jun 25.
7
Racial, ethnic, and socioeconomic diversity and outcomes of patients with graft-versus-host disease: a CIBMTR analysis.患者移植物抗宿主病的种族、民族和社会经济多样性及其结果:CIBMTR 分析。
Blood Adv. 2024 Sep 24;8(18):4963-4976. doi: 10.1182/bloodadvances.2024013074.
8
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update.国际移植和细胞治疗长期幸存者的筛查和预防建议:2023 年更新版。
Bone Marrow Transplant. 2024 Jun;59(6):717-741. doi: 10.1038/s41409-023-02190-2. Epub 2024 Feb 27.
9
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update.国际移植和细胞治疗长期幸存者筛查和预防建议:2023 年更新版。
Transplant Cell Ther. 2024 Apr;30(4):349-385. doi: 10.1016/j.jtct.2023.12.001. Epub 2024 Feb 27.
10
Incidence and predictors of recurrent sick leave in survivors who returned to work after allogeneic hematopoietic cell transplantation.异基因造血细胞移植后重返工作的幸存者中复发性病假的发生率和预测因素。
J Cancer Surviv. 2023 Jun;17(3):781-794. doi: 10.1007/s11764-022-01250-8. Epub 2022 Sep 1.

本文引用的文献

1
Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial.患者报告结局和社会经济地位作为造血干细胞移植后临床结局的预测因素:来自血液和骨髓移植临床试验网络0902试验的一项研究
Biol Blood Marrow Transplant. 2016 Dec;22(12):2256-2263. doi: 10.1016/j.bbmt.2016.08.016. Epub 2016 Aug 23.
2
Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation.造血细胞移植后的经济困难与患者报告的结局
Biol Blood Marrow Transplant. 2016 Aug;22(8):1504-1510. doi: 10.1016/j.bbmt.2016.05.008. Epub 2016 May 13.
3
Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients.造血干细胞移植受者的社会经济地位低下、不良基因表达谱与临床结局
Clin Cancer Res. 2016 Jan 1;22(1):69-78. doi: 10.1158/1078-0432.CCR-15-1344. Epub 2015 Aug 18.
4
Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantation.异基因造血细胞移植1年幸存者的社会经济状况与长期预后的关联
Bone Marrow Transplant. 2015 Oct;50(10):1326-30. doi: 10.1038/bmt.2015.166. Epub 2015 Jul 20.
5
Practice variation in physician referral for allogeneic hematopoietic cell transplantation.医师推荐行异基因造血细胞移植的实践差异。
Bone Marrow Transplant. 2013 Jan;48(1):63-7. doi: 10.1038/bmt.2012.95. Epub 2012 Jun 18.
6
Economics of hematopoietic cell transplantation.造血细胞移植的经济学。
Blood. 2012 Aug 23;120(8):1545-51. doi: 10.1182/blood-2012-05-426783. Epub 2012 Jun 13.
7
Economic survivorship stress is associated with poor health-related quality of life among distressed survivors of hematopoietic stem cell transplantation.经济生存压力与造血干细胞移植后痛苦幸存者的健康相关生活质量较差有关。
Psychooncology. 2013 Apr;22(4):911-21. doi: 10.1002/pon.3091. Epub 2012 May 18.
8
Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).造血细胞移植后长期生存者的不良心理结局:来自骨髓移植生存者研究(BMTSS)的报告。
Blood. 2011 Oct 27;118(17):4723-31. doi: 10.1182/blood-2011-04-348730. Epub 2011 Aug 5.
9
The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality.根据美国国立卫生研究院共识标准确定的慢性移植物抗宿主病的全球严重程度与总生存和非复发死亡率相关。
Haematologica. 2011 Nov;96(11):1678-84. doi: 10.3324/haematol.2011.049841. Epub 2011 Jul 26.
10
Systolic blood pressure, socioeconomic status, and biobehavioral risk factors in a nationally representative US young adult sample.在一个具有全国代表性的美国年轻成年人样本中,收缩压、社会经济地位和生物行为风险因素。
Hypertension. 2011 Aug;58(2):161-6. doi: 10.1161/HYPERTENSIONAHA.111.171272. Epub 2011 Jul 5.

社会经济地位与慢性移植物抗宿主病结局的关系。

Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes.

机构信息

Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, Ohio.

Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.

出版信息

Biol Blood Marrow Transplant. 2018 Feb;24(2):393-399. doi: 10.1016/j.bbmt.2017.10.009. Epub 2017 Oct 12.

DOI:10.1016/j.bbmt.2017.10.009
PMID:29032275
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5767523/
Abstract

Chronic graft-versus host disease (GVHD) is a chronic and disabling complication after hematopoietic cell transplantation (HCT). It is important to understand the association of socioeconomic status (SES) with health outcomes in patients with chronic GVHD because of the impaired physical health and dependence on intensive and prolonged health care utilization needs in these patients. We evaluated the association of SES with survival and quality of life (QOL) in a cohort of 421 patients with chronic GVHD enrolled on the Chronic GVHD Consortium Improving Outcomes Assessment study. Income, education, marital status, and work status were analyzed to determine the associations with patient-reported outcomes at the time of enrollment, nonrelapse mortality (NRM), and overall mortality. Higher income (P = .004), ability to work (P < .001), and having a partner (P = .021) were associated with better mean Lee chronic GVHD symptom scores. Higher income (P = .048), educational level (P = .044), and ability to work (P < .001) also were significantly associated with better QOL and improved activity. In multivariable models, higher income and ability to return to work were both significantly associated with better chronic GVHD Lee symptom scores, but income was not associated with activity level, QOL, or physical/mental functioning. The inability to return to work (hazard ratio, 1.82; P = .019) was associated with worse overall mortality, whereas none of the SES indicators were associated with NRM. Income, race, and education did not have statistically significant associations with survival. In summary, we did not observe an association between SES variables and survival or NRM in patients with chronic GVHD, although we found some association with patient-reported outcomes, such as symptom burden. Higher income status was associated with less severe chronic GVHD symptoms. More research is needed to understand the psychosocial, biological, and environmental factors that mediate this association of SES with major HCT outcomes.

摘要

慢性移植物抗宿主病(GVHD)是造血细胞移植(HCT)后的一种慢性和致残性并发症。了解社会经济地位(SES)与慢性 GVHD 患者健康结果之间的关联非常重要,因为这些患者的身体健康受损,需要依赖密集和长期的医疗保健利用。我们评估了 SES 与慢性 GVHD 队列中 421 名患者的生存和生活质量(QOL)之间的关联,这些患者参加了慢性 GVHD 联盟改善评估研究。收入、教育、婚姻状况和工作状况进行了分析,以确定与患者在入组时报告的结果、非复发死亡率(NRM)和总死亡率的关系。较高的收入(P = .004)、工作能力(P < .001)和有伴侣(P = .021)与平均 Lee 慢性 GVHD 症状评分较高相关。较高的收入(P = .048)、教育水平(P = .044)和工作能力(P < .001)也与较好的 QOL 和活动能力显著相关。在多变量模型中,较高的收入和恢复工作的能力与 Lee 慢性 GVHD 症状评分的改善均显著相关,但收入与活动水平、QOL 或身体/精神功能无关。无法恢复工作(危险比,1.82;P = .019)与较差的总死亡率相关,而 SES 指标均与 NRM 无关。收入、种族和教育与生存无统计学显著关联。总之,我们没有观察到 SES 变量与慢性 GVHD 患者的生存或 NRM 之间存在关联,尽管我们发现一些与患者报告的结果有关,如症状负担。较高的收入状况与慢性 GVHD 症状较轻有关。需要更多的研究来了解 SES 与主要 HCT 结果相关的社会心理、生物和环境因素。